1
|
Liang H, Qin L, Feng R, Shim J, Huang X, Xu X, Zhao D, Yu Z, Boczek T, Li M, Tong Y, Huang J, Gao Q, Wang L, Cao X, Liu D, Du K, Xu J, Zhao Y, Wang W, Seehus CR, Zhao W, Guo F. Increased Na V1.2 expression and its interaction with CaM contribute to the hyperexcitability induced by prolonged inhibition of CaMKII. Epilepsia 2025. [PMID: 40119845 DOI: 10.1111/epi.18377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2024] [Revised: 03/05/2025] [Accepted: 03/05/2025] [Indexed: 03/24/2025]
Abstract
OBJECTIVE Dysfunction of calcium/calmodulin (CaM)-dependent kinase II (CaMKII) has been involved in hyperexcitability-related disorders including epilepsy. However, the relationship between CaMKII and neuronal excitability remains unclear. METHODS Neuronal excitability was detected in vivo and in vitro by electroencephalography (EEG), patch clamp and multi-electrode array (MEA), respectively. Next, we assessed the currents of voltage-gated sodium channels (VGSCs) by patch clamp, and mRNA and protein expressions of VGSCs were determined by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot, respectively. Meanwhile, the association between the nuclear receptor subfamily 4 group A member 2 (NR4A2) and promoters of Scn2a, was determined by chromatin immunoprecipitation (ChIP)-qPCR. In addition, we utilized co-immunoprecipitation (Co-IP), immunofluorescence labeling, and pull-down to determine the interaction between VGSCs and CaM. RESULTS Prolonged CaMKII inhibition by KN93, an inhibitor of CaMKII, for 24 h and CaMKII knockdown induced more seizure-like events in Wistar rats, TRM rats and C57BL/6 mice, and led to hyperexcitability in primary hippocampal neurons and human induced-pluripotent stem cell (hiPSC)-derived cortical neurons. In addition, prolonged CaMKII inhibition resulted in elevated persistent sodium current (INaP)/transient sodium current (INaT) and increased mRNA and protein expressions of NaV1.2. Meanwhile, prolonged CaMKII inhibition by KN93 decreased NR4A2 expression and contributed to a transcriptional repression role of NR4A2 in Scn2a regulation, leading to increased NaV1.2 expression. Moreover, an increased interaction between NaV1.2 and CaM was attributable to enhanced binding of CaM to the isoleucine-glutamine (IQ) domain at the C-terminus of the NaV1.2 channel, which may also lead to the potentiation in INaP/INaT and channel activity. Furthermore, a peptide that antagonized CaM binding to NaV1.2 IQ domain (ACNp) rescued hyperexcitability following prolonged CaMKII inhibition. SIGNIFICANCE We unveiled that prolonged CaMKII inhibition induced hyperexcitability through increasing the expression of NaV1.2 and its association with CaM. Thus, our study uncovers a novel signaling mechanism by which CaMKII maintains appropriate neuronal excitability.
Collapse
Affiliation(s)
- Hongyue Liang
- Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang, China
| | - Ling Qin
- Department of Physiology, China Medical University, Shenyang, China
| | - Rui Feng
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Jaehoon Shim
- Department of Neurobiology, Boston Children's Hospital, Boston, Massachusetts, USA
| | - Xuan Huang
- Department of Neurobiology, Boston Children's Hospital, Boston, Massachusetts, USA
| | - Xiaoxue Xu
- Department of Neurology, The First Hospital of China Medical University, Shenyang, China
| | - Dongyi Zhao
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Zhiyi Yu
- Division of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China
| | - Tomasz Boczek
- Department of Molecular Neurochemistry, Medical University of Lodz, Lodz, Poland
| | - Meixuan Li
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Yu Tong
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Junwei Huang
- Department of Neurobiology, Boston Children's Hospital, Boston, Massachusetts, USA
| | - Qinghua Gao
- Department of Developmental Cell Biology, China Medical University, Shenyang, China
| | - Li Wang
- Department of Developmental Cell Biology, China Medical University, Shenyang, China
| | - Xinyu Cao
- Department of Developmental Cell Biology, China Medical University, Shenyang, China
| | - Dongxin Liu
- Department of Developmental Cell Biology, China Medical University, Shenyang, China
| | - Ke Du
- Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China
| | - Jianjun Xu
- Department of Physiology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
| | - Yue Zhao
- Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province, China
| | - Wuyang Wang
- Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China
| | - Corey Ray Seehus
- Department of Neurobiology, Boston Children's Hospital, Boston, Massachusetts, USA
| | - Weidong Zhao
- Department of Developmental Cell Biology, China Medical University, Shenyang, China
- Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province, China
| | - Feng Guo
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
- Department of Pharmacy, The Fourth Affiliated Hospital of China Medical University, Shenyang, China
| |
Collapse
|
2
|
Epilepsy-Induced High Affinity Blockade of the Cardiac Sodium Current INa by Lamotrigine; A Potential for Acquired Arrythmias. Pharmaceuticals (Basel) 2022; 15:ph15101208. [PMID: 36297320 PMCID: PMC9609666 DOI: 10.3390/ph15101208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Revised: 09/20/2022] [Accepted: 09/22/2022] [Indexed: 11/30/2022] Open
Abstract
Lamotrigine is widely prescribed to treat bipolar neurological disorder and epilepsy. It exerts its antiepileptic action by blocking voltage-gated sodium channels in neurons. Recently, the US Food and Drug Administration issued a warning on the use of Lamotrigine after observations of conduction anomalies and Brugada syndrome patterns on the electrocardiograms of epileptic patients treated with the drug. Brugada syndrome and conduction disturbance are both associated with alterations of the cardiac sodium current (INa) kinetics and amplitude. In this study, we used the patch clamp technique on cardiomyocytes from epileptic rats to test the hypothesis that Lamotrigine also blocks INa in the heart. We found that Lamotrigine inhibited 60% of INa peak amplitude and reduced cardiac excitability in epileptic rats but had little effect in sham animals. Moreover, Lamotrigine inhibited 67% of INaL and, more importantly, prolonged the action potential refractory period in epileptic animals. Our results suggest that enhanced affinity of Lamotrigine for INa may in part explain the clinical phenotypes observed in epileptic patients.
Collapse
|
3
|
Calcium-/Calmodulin-Dependent Protein Kinase II (CaMKII) Inhibition Induces Learning and Memory Impairment and Apoptosis. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2022; 2021:4635054. [PMID: 34976299 PMCID: PMC8718318 DOI: 10.1155/2021/4635054] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/07/2021] [Accepted: 11/18/2021] [Indexed: 12/20/2022]
Abstract
Objectives Inhibition of calcium-/calmodulin- (CaM-) dependent kinase II (CaMKII) is correlated with epilepsy. However, the specific mechanism that underlies learning and memory impairment and neuronal death by CaMKII inhibition remains unclear. Materials and Methods In this study, KN93, a CaMKII inhibitor, was used to investigate the role of CaMKII during epileptogenesis. We first identified differentially expressed genes (DEGs) in primary cultured hippocampal neurons with or without KN93 treatment using RNA-sequencing. Then, the impairment of learning and memory by KN93-induced CaMKII inhibition was assessed using the Morris water maze test. In addition, Western blotting, immunohistochemistry, and TUNEL staining were performed to determine neuronal death, apoptosis, and the relative signaling pathway. Results KN93-induced CaMKII inhibition decreased cAMP response element-binding (CREB) protein activity and impaired learning and memory in Wistar and tremor (TRM) rats, an animal model of genetic epilepsy. CaMKII inhibition also induced neuronal death and reactive astrocyte activation in both the Wistar and TRM hippocampi, deregulating mitogen-activated protein kinases. Meanwhile, neuronal death and neuron apoptosis were observed in PC12 and primary cultured hippocampal neurons after exposure to KN93, which was reversed by SP600125, an inhibitor of c-Jun N-terminal kinase (JNK). Conclusions CaMKII inhibition caused learning and memory impairment and apoptosis, which might be related to dysregulated JNK signaling.
Collapse
|
4
|
Precise spatiotemporal control of voltage-gated sodium channels by photocaged saxitoxin. Nat Commun 2021; 12:4171. [PMID: 34234116 PMCID: PMC8263607 DOI: 10.1038/s41467-021-24392-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Accepted: 06/09/2021] [Indexed: 02/06/2023] Open
Abstract
Here we report the pharmacologic blockade of voltage-gated sodium ion channels (NaVs) by a synthetic saxitoxin derivative affixed to a photocleavable protecting group. We demonstrate that a functionalized saxitoxin (STX-eac) enables exquisite spatiotemporal control of NaVs to interrupt action potentials in dissociated neurons and nerve fiber bundles. The photo-uncaged inhibitor (STX-ea) is a nanomolar potent, reversible binder of NaVs. We use STX-eac to reveal differential susceptibility of myelinated and unmyelinated axons in the corpus callosum to NaV-dependent alterations in action potential propagation, with unmyelinated axons preferentially showing reduced action potential fidelity under conditions of partial NaV block. These results validate STX-eac as a high precision tool for robust photocontrol of neuronal excitability and action potential generation.
Collapse
|
5
|
Abnormal changes in voltage-gated sodium channels subtypes Na V 1.1, Na V 1.2, Na V 1.3, Na V 1.6 and CaM/CaMKII pathway in low-grade astrocytoma. Neurosci Lett 2018; 674:148-155. [DOI: 10.1016/j.neulet.2018.03.047] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2018] [Revised: 03/20/2018] [Accepted: 03/20/2018] [Indexed: 12/19/2022]
|
6
|
Jaffe DB, Brenner R. A computational model for how the fast afterhyperpolarization paradoxically increases gain in regularly firing neurons. J Neurophysiol 2018; 119:1506-1520. [PMID: 29357445 DOI: 10.1152/jn.00385.2017] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
The gain of a neuron, the number and frequency of action potentials triggered in response to a given amount of depolarizing injection, is an important behavior underlying a neuron's function. Variations in action potential waveform can influence neuronal discharges by the differential activation of voltage- and ion-gated channels long after the end of a spike. One component of the action potential waveform, the afterhyperpolarization (AHP), is generally considered an inhibitory mechanism for limiting firing rates. In dentate gyrus granule cells (DGCs) expressing fast-gated BK channels, large fast AHPs (fAHP) are paradoxically associated with increased gain. In this article, we describe a mechanism for this behavior using a computational model. Hyperpolarization provided by the fAHP enhances activation of a dendritic inward current (a T-type Ca2+ channel is suggested) that, in turn, boosts rebound depolarization at the soma. The model suggests that the fAHP may both reduce Ca2+ channel inactivation and, counterintuitively, enhance its activation. The magnitude of the rebound depolarization, in turn, determines the activation of a subsequent, slower inward current (a persistent Na+ current is suggested) limiting the interspike interval. Simulations also show that the effect of AHP on gain is also effective for physiologically relevant stimulation; varying AHP amplitude affects interspike interval across a range of "noisy" stimulus frequency and amplitudes. The mechanism proposed suggests that small fAHPs in DGCs may contribute to their limited excitability. NEW & NOTEWORTHY The afterhyperpolarization (AHP) is canonically viewed as a major factor underlying the refractory period, serving to limit neuronal firing rate. We recently reported that enhancing the amplitude of the fast AHP (fAHP) in a relatively slowly firing neuron (vs. fast spiking neurons) expressing fast-gated BK channels augments neuronal excitability. In this computational study, we present a novel, quantitative hypothesis for how varying the amplitude of the fAHP can, paradoxically, influence a subsequent spike tens of milliseconds later.
Collapse
Affiliation(s)
- David B Jaffe
- Department of Biology, UTSA Neurosciences Institute, University of Texas at San Antonio , San Antonio, Texas
| | - Robert Brenner
- Department of Cell and Integrative Physiology, University of Texas Health Science Center at San Antonio , San Antonio, Texas
| |
Collapse
|
7
|
Functional Neuroplasticity in the Nucleus Tractus Solitarius and Increased Risk of Sudden Death in Mice with Acquired Temporal Lobe Epilepsy. eNeuro 2017; 4:eN-NWR-0319-17. [PMID: 29085908 PMCID: PMC5661358 DOI: 10.1523/eneuro.0319-17.2017] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2017] [Revised: 10/13/2017] [Accepted: 10/16/2017] [Indexed: 12/23/2022] Open
Abstract
Sudden unexpected death in epilepsy (SUDEP) is the leading cause of death in individuals with refractory acquired epilepsy. Cardiorespiratory failure is the most likely cause in most cases, and central autonomic dysfunction has been implicated as a contributing factor to SUDEP. Neurons of the nucleus tractus solitarius (NTS) in the brainstem vagal complex receive and integrate vagally mediated information regarding cardiorespiratory and other autonomic functions, and GABAergic inhibitory NTS neurons play an essential role in modulating autonomic output. We assessed the activity of GABAergic NTS neurons as a function of epilepsy development in the pilocarpine-induced status epilepticus (SE) model of temporal lobe epilepsy (TLE). Compared with age-matched controls, mice that survived SE had significantly lower survival rates by 150 d post-SE. GABAergic NTS neurons from mice that survived SE displayed a glutamate-dependent increase in spontaneous action potential firing rate by 12 wks post-SE. Increased spontaneous EPSC frequency was also detected, but vagal afferent synaptic release properties were unaltered, suggesting that an increase in glutamate release from central neurons developed in the NTS after SE. Our results indicate that long-term changes in glutamate release and activity of GABAergic neurons emerge in the NTS in association with epileptogenesis. These changes might contribute to increased risk of cardiorespiratory dysfunction and sudden death in this model of TLE.
Collapse
|
8
|
|
9
|
Jewett KA, Zhu J, Tsai NP. The tumor suppressor p53 guides GluA1 homeostasis through Nedd4-2 during chronic elevation of neuronal activity. J Neurochem 2015; 135:226-33. [PMID: 26250624 DOI: 10.1111/jnc.13271] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2015] [Revised: 07/09/2015] [Accepted: 07/27/2015] [Indexed: 12/19/2022]
Abstract
Chronic activity perturbation in neurons can trigger homeostatic mechanisms to restore the baseline function. Although the importance and dysregulation of neuronal activity homeostasis has been implicated in neurological disorders such as epilepsy, the complete signaling by which chronic changes in neuronal activity initiate the homeostatic mechanisms is unclear. We report here that the tumor suppressor p53 and its signaling are involved in neuronal activity homeostasis. Upon chronic elevation of neuronal activity in primary cortical neuron cultures, the ubiquitin E3 ligase, murine double minute- 2 (Mdm2), is phosphorylated by the kinase Akt. Phosphorylated Mdm2 triggers the degradation of p53 and subsequent induction of a p53 target gene, neural precursor cell expressed developmentally down-regulated gene 4-like (Nedd4-2). Nedd4-2 encodes another ubiquitin E3 ligase. We identified glutamate receptor subunit 1 (GluA1), subunit of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors as a novel substrate of Nedd4-2. The regulation of GluA1 level is known to be crucial for neuronal activity homeostasis. We confirmed that, by pharmacologically inhibiting Mdm2-mediated p53 degradation or genetically reducing Nedd4-2 in a mouse model, the GluA1 ubiquitination and down-regulation induced by chronically elevated neuronal activity are both attenuated. Our findings demonstrate the first direct function of p53 in neuronal homeostasis and elucidate a new mechanism by which cortical neurons respond to chronic activity perturbation.
Collapse
Affiliation(s)
- Kathryn A Jewett
- Department of Molecular and Integrative Physiology, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Jiuhe Zhu
- Department of Molecular and Integrative Physiology, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Nien-Pei Tsai
- Department of Molecular and Integrative Physiology, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.,Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| |
Collapse
|
10
|
Lv X, Guo F, Xu X, Chen Z, Sun X, Min D, Cao Y, Shi X, Wang L, Chen T, Shaw C, Gao H, Hao L, Cai J. Abnormal alterations in the Ca²⁺/CaV1.2/calmodulin/caMKII signaling pathway in a tremor rat model and in cultured hippocampal neurons exposed to Mg²⁺-free solution. Mol Med Rep 2015; 12:6663-71. [PMID: 26299765 PMCID: PMC4626152 DOI: 10.3892/mmr.2015.4227] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2014] [Accepted: 07/21/2015] [Indexed: 11/05/2022] Open
Abstract
Voltage-dependent calcium channels (VDCCs) are key elements in epileptogenesis. There are several binding-sites linked to calmodulin (CaM) and several potential CaM-dependent protein kinase II (CaMKII)-mediated phosphorylation sites in CaV1.2. The tremor rat model (TRM) exhibits absence‑like seizures from 8 weeks of age. The present study was performed to detect changes in the Ca2+/CaV1.2/CaM/CaMKII pathway in TRMs and in cultured hippocampal neurons exposed to Mg2+‑free solution. The expression levels of CaV1.2, CaM and phosphorylated CaMKII (p‑CaMKII; Thr‑286) in these two models were examined using immunofluorescence and western blotting. Compared with Wistar rats, the expression levels of CaV1.2 and CaM were increased, and the expression of p‑CaMKII was decreased in the TRM hippocampus. However, the expression of the targeted proteins was reversed in the TRM temporal cortex. A significant increase in the expression of CaM and decrease in the expression of CaV1.2 were observed in the TRM cerebellum. In the cultured neuron model, p‑CaMKII and CaV1.2 were markedly decreased. In addition, neurons exhibiting co‑localized expression of CaV1.2 and CaM immunoreactivities were detected. Furthermore, intracellular calcium concentrations were increased in these two models. For the first time, o the best of our knowledge, the data of the present study suggested that abnormal alterations in the Ca2+/CaV1.2/CaM/CaMKII pathway may be involved in epileptogenesis and in the phenotypes of TRMs and cultured hippocampal neurons exposed to Mg2+‑free solution.
Collapse
Affiliation(s)
- Xintong Lv
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Feng Guo
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Xiaoxue Xu
- Department of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Zaixing Chen
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Xuefei Sun
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Dongyu Min
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Yonggang Cao
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Xianbao Shi
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Lei Wang
- Molecular Therapeutics Research Group, School of Pharmacy, Queen's University, Belfast BT7 1NN, United Kingdom
| | - Tianbao Chen
- Molecular Therapeutics Research Group, School of Pharmacy, Queen's University, Belfast BT7 1NN, United Kingdom
| | - Chris Shaw
- Molecular Therapeutics Research Group, School of Pharmacy, Queen's University, Belfast BT7 1NN, United Kingdom
| | - Huiling Gao
- College of Life and Health Sciences, Northeastern University, Shenyang, Liaoning 110001, P.R. China
| | - Liying Hao
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| | - Jiqun Cai
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China
| |
Collapse
|
11
|
Biet M, Morin N, Lessard-Beaudoin M, Graham RK, Duss S, Gagné J, Sanon NT, Carmant L, Dumaine R. Prolongation of Action Potential Duration and QT Interval During Epilepsy Linked to Increased Contribution of Neuronal Sodium Channels to Cardiac Late Na
+
Current. Circ Arrhythm Electrophysiol 2015; 8:912-20. [DOI: 10.1161/circep.114.002693] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/27/2014] [Accepted: 06/01/2015] [Indexed: 11/16/2022]
Affiliation(s)
- Michael Biet
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Nathalie Morin
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Melissa Lessard-Beaudoin
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Rona K. Graham
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Sandra Duss
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Jonathan Gagné
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Nathalie T. Sanon
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Lionel Carmant
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| | - Robert Dumaine
- From the Département de Pharmacologie et Physiologie, Université de Sherbrooke, Sherbrooke, Canada (M.B., N.M., M.L.-B., R.K.G., R.D.); and Department of Pediatrics, Centre de Recherche du CHU Sainte Justine, Université de Montréal, Montréal, Quebec, Canada (S.D., J.G., N.T.S., L.C.)
| |
Collapse
|
12
|
Guo F, Zhou PD, Gao QH, Gong J, Feng R, Xu XX, Liu SY, Hu HY, Zhao MM, Adam HC, Cai JQ, Hao LY. Low-Mg(2+) treatment increases sensitivity of voltage-gated Na(+) channels to Ca(2+)/calmodulin-mediated modulation in cultured hippocampal neurons. Am J Physiol Cell Physiol 2015; 308:C594-605. [PMID: 25652447 DOI: 10.1152/ajpcell.00174.2014] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2014] [Accepted: 01/30/2015] [Indexed: 02/06/2023]
Abstract
Culture of hippocampal neurons in low-Mg(2+) medium (low-Mg(2+) neurons) results in induction of continuous seizure activity. However, the underlying mechanism of the contribution of low Mg(2+) to hyperexcitability of neurons has not been clarified. Our data, obtained using the patch-clamp technique, show that voltage-gated Na(+) channel (VGSC) activity, which is associated with a persistent, noninactivating Na(+) current (INa,P), was modulated by calmodulin (CaM) in a concentration-dependent manner in normal and low-Mg(2+) neurons, but the channel activity was more sensitive to Ca(2+)/CaM regulation in low-Mg(2+) than normal neurons. The increased sensitivity of VGSCs in low-Mg(2+) neurons was partially retained when CaM12 and CaM34, CaM mutants with disabled binding sites in the N or C lobe, were used but was diminished when CaM1234, a CaM mutant in which all four Ca(2+) sites are disabled, was used, indicating that functional Ca(2+)-binding sites from either lobe of CaM are required for modulation of VGSCs in low-Mg(2+) neurons. Furthermore, the number of neurons exhibiting colocalization of CaM with the VGSC subtypes NaV1.1, NaV1.2, and NaV1.3 was significantly higher in low- Mg(2+) than normal neurons, as shown by immunofluorescence. Our main finding is that low-Mg(2+) treatment increases sensitivity of VGSCs to Ca(2+)/CaM-mediated regulation. Our data reveal that CaM, as a core regulating factor, connects the functional roles of the three main intracellular ions, Na(+), Ca(2+), and Mg(2+), by modulating VGSCs and provides a possible explanation for the seizure discharge observed in low-Mg(2+) neurons.
Collapse
Affiliation(s)
- Feng Guo
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Pei-Dong Zhou
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Qing-Hua Gao
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Jian Gong
- Department of Clinical Pharmacy, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China
| | - Rui Feng
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Xiao-Xue Xu
- Department of Neurology, The First Hospital of China Medical University, Shenyang, China; and
| | - Shu-Yuan Liu
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Hui-Yuan Hu
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Mei-Mi Zhao
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Hogan-Cann Adam
- Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Ji-Qun Cai
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| | - Li-Ying Hao
- Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China
| |
Collapse
|
13
|
Serikawa T, Mashimo T, Kuramoro T, Voigt B, Ohno Y, Sasa M. Advances on genetic rat models of epilepsy. Exp Anim 2014; 64:1-7. [PMID: 25312505 PMCID: PMC4329510 DOI: 10.1538/expanim.14-0066] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Considering the suitability of laboratory rats in epilepsy research, we and other groups
have been developing genetic models of epilepsy in this species. After epileptic rats or
seizure-susceptible rats were sporadically found in outbred stocks, the epileptic traits
were usually genetically-fixed by selective breeding. So far, the absence seizure models
GAERS and WAG/Rij, audiogenic seizure models GEPR-3 and GEPR-9, generalized tonic-clonic
seizure models IER, NER and WER, and Canavan-disease related epileptic models TRM and SER
have been established. Dissection of the genetic bases including causative genes in these
epileptic rat models would be a significant step toward understanding epileptogenesis.
N-ethyl-N-nitrosourea (ENU) mutagenesis provides a systematic approach which allowed us to
develop two novel epileptic rat models: heat-induced seizure susceptible (Hiss) rats with
an Scn1a missense mutation and autosomal dominant lateral temporal epilepsy (ADLTE) model
rats with an Lgi1 missense mutation. In addition, we have established episodic ataxia type
1 (EA1) model rats with a Kcna1 missense mutation derived from the ENU-induced rat mutant
stock, and identified a Cacna1a missense mutation in a N-Methyl-N-nitrosourea
(MNU)-induced mutant rat strain GRY, resulting in the discovery of episodic ataxia type 2
(EA2) model rats. Thus, epileptic rat models have been established on the two paths:
‘phenotype to gene’ and ‘gene to phenotype’. In the near future, development of novel
epileptic rat models will be extensively promoted by the use of sophisticated genome
editing technologies.
Collapse
Affiliation(s)
- Tadao Serikawa
- Graduate School of Medicine, Kyoto University, Sakyo-ku 606-8501; Laboratory of Pharmacology, Osaka University of Pharmaceutical Sciences, Takatsuki 569-1094, Japan
| | | | | | | | | | | |
Collapse
|
14
|
Baek JH, Rubinstein M, Scheuer T, Trimmer JS. Reciprocal changes in phosphorylation and methylation of mammalian brain sodium channels in response to seizures. J Biol Chem 2014; 289:15363-73. [PMID: 24737319 PMCID: PMC4140893 DOI: 10.1074/jbc.m114.562785] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2014] [Revised: 04/10/2014] [Indexed: 12/19/2022] Open
Abstract
Voltage-gated sodium (Nav) channels initiate action potentials in brain neurons and are primary therapeutic targets for anti-epileptic drugs controlling neuronal hyperexcitability in epilepsy. The molecular mechanisms underlying abnormal Nav channel expression, localization, and function during development of epilepsy are poorly understood but can potentially result from altered posttranslational modifications (PTMs). For example, phosphorylation regulates Nav channel gating, and has been proposed to contribute to acquired insensitivity to anti-epileptic drugs exhibited by Nav channels in epileptic neurons. However, whether changes in specific brain Nav channel PTMs occur acutely in response to seizures has not been established. Here, we show changes in PTMs of the major brain Nav channel, Nav1.2, after acute kainate-induced seizures. Mass spectrometry-based proteomic analyses of Nav1.2 purified from the brains of control and seizure animals revealed a significant down-regulation of phosphorylation at nine sites, primarily located in the interdomain I-II linker, the region of Nav1.2 crucial for phosphorylation-dependent regulation of activity. Interestingly, Nav1.2 in the seizure samples contained methylated arginine (MeArg) at three sites. These MeArgs were adjacent to down-regulated sites of phosphorylation, and Nav1.2 methylation increased after seizure. Phosphorylation and MeArg were not found together on the same tryptic peptide, suggesting reciprocal regulation of these two PTMs. Coexpression of Nav1.2 with the primary brain arginine methyltransferase PRMT8 led to a surprising 3-fold increase in Nav1.2 current. Reciprocal regulation of phosphorylation and MeArg of Nav1.2 may underlie changes in neuronal Nav channel function in response to seizures and also contribute to physiological modulation of neuronal excitability.
Collapse
Affiliation(s)
- Je-Hyun Baek
- From the Department of Neurobiology, Physiology, and Behavior and
| | - Moran Rubinstein
- the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195-7280
| | - Todd Scheuer
- the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195-7280
| | - James S Trimmer
- From the Department of Neurobiology, Physiology, and Behavior and the Department of Physiology and Membrane Biology, University of California, Davis, California 95616 and
| |
Collapse
|
15
|
Du Z, Tian K. Effect of ytterbium on sodium current and its kinetics in rat hippocampal neurons. CHINESE SCIENCE BULLETIN-CHINESE 2014. [DOI: 10.1007/s11434-013-0078-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Licko T, Seeger N, Zellinger C, Russmann V, Matagne A, Potschka H. Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model. Epilepsia 2013; 54:1176-85. [PMID: 23614482 DOI: 10.1111/epi.12196] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/12/2013] [Indexed: 12/22/2022]
Abstract
PURPOSE The antiepileptic drug, lacosamide, exerts its therapeutic activity by enhancing slow inactivation of voltage-gated sodium channels. Because putative preventive or disease-modifying effects of drugs may affect epileptogenesis, intrinsic severity, and comorbidities, it is of particular interest to assess the effect of lacosamide on the development of epilepsy and associated cellular alterations. METHODS The effect of lacosamide was evaluated in an electrical rat status epilepticus (SE) model with a 24-day treatment phase following induction of SE. The impact of lacosamide on the development of spontaneous seizures based on continuous video-electroencephalography (EEG) monitoring, as well as the impact on neuronal cell loss and alterations in hippocampal neurogenesis, was assessed. KEY FINDINGS Neither low-dose nor high-dose lacosamide affected the development of spontaneous seizures. A dose-dependent neuroprotective effect of lacosamide with significant reduction of neuronal cell loss was observed in the hippocampal CA1 region, as well as in the piriform cortex. In addition, lacosamide attenuated the impact of SE on the rate of hippocampal cell neurogenesis. Moreover, lacosamide prevented a significant rise in the number of persistent basal dendrites. SIGNIFICANCE Our data do not support an antiepileptogenic effect of lacosamide. However, because lacosamide reduced SE-associated cellular alterations, it would be of interest to determine whether these effects indicate a putative disease-modifying effect of lacosamide in future studies.
Collapse
Affiliation(s)
- Thomas Licko
- Institute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilian-University, Munich, Germany
| | | | | | | | | | | |
Collapse
|